معرفی
Professor Paul Kalra is an Honorary Clinical Senior Lecturer at the School of Health & Wellbeing, University of Portsmouth. He is affiliated with Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital. His primary focus is on heart failure management, iron deficiency treatment strategies, and clinical trial design. His research emphasizes intravenous iron therapies (e.g., ferric derisomaltose) in heart failure populations, particularly regarding renal function interactions, infection risks, and comorbidities like anemia and chronic kidney disease.
- Key Projects: Lead investigator of the IRONMAN trial evaluating intravenous iron efficacy in heart failure patients
- Research Themes: Cardiac pharmacotherapy, clinical outcomes analysis, and evidence-based guidelines for iron deficiency management
Publications (2023-2025) highlight his work on trial adjudication, drug interactions (e.g., SGLT2 inhibitors), and novel furosemide delivery methods. He collaborates extensively with global experts in cardiology and clinical epidemiology.